BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
50.05
1.05 (2.14%)
At close: Sep 26, 2025, 3:59 PM
50.00
-0.10%
After-hours: Sep 26, 2025, 07:55 PM EDT
BridgeBio Pharma Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Net Product Revenue Revenue | 71.5M | 36.74M |
| Net Product Revenue Revenue Growth | +94.62% | n/a |
| Royalty Revenue Revenue | 1.62M | n/a |
| Royalty Revenue Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 128.54M | 106.36M | 94.78M | 68.82M | 59.52M | 64.51M | 47.58M | 35.78M | 36.12M | 31.11M | 31.86M | 31.19M | 36.43M | 43.71M | 54.75M | 46.08M | 45.97M | 45.41M | 37.44M | 36.02M | 37.97M | 34.26M | 34.97M | 23.5M | 16.92M | 18.9M | 14.38M | 10.31M | 10.89M | 8.01M |
| Selling, General, and Administrative Revenue Growth | +20.85% | +12.22% | +37.73% | +15.62% | -7.73% | +35.58% | +33.00% | -0.96% | +16.12% | -2.37% | +2.16% | -14.38% | -16.67% | -20.16% | +18.80% | +0.25% | +1.24% | +21.29% | +3.95% | -5.14% | +10.82% | -2.03% | +48.85% | +38.88% | -10.48% | +31.42% | +39.51% | -5.35% | +36.02% | n/a |
| Research and Development Revenue | 111.23M | 111.43M | 130.35M | 120.44M | 114.69M | 140.97M | 130.23M | 125.14M | 108.09M | 93.51M | 91.55M | 92.51M | 108.4M | 107.65M | 123.75M | 104.31M | 102.07M | 122.56M | 90.17M | 92.05M | 86.6M | 68.22M | 57.48M | 55.28M | 52.33M | 44.85M | 51.2M | 31.15M | 23.89M | 33.83M |
| Research and Development Revenue Growth | -0.18% | -14.51% | +8.22% | +5.01% | -18.64% | +8.25% | +4.07% | +15.77% | +15.59% | +2.14% | -1.04% | -14.66% | +0.70% | -13.01% | +18.64% | +2.19% | -16.72% | +35.91% | -2.04% | +6.30% | +26.93% | +18.68% | +3.99% | +5.63% | +16.67% | -12.40% | +64.38% | +30.37% | -29.38% | n/a |